Luciferin Amides Enable in Vivo Bioluminescence Detection of Endogenous Fatty Acid Amide Hydrolase Activity

被引:64
|
作者
Mofford, David M. [1 ]
Adams, Spencer T., Jr. [1 ]
Reddy, G. S. Kiran Kumar [1 ]
Reddy, Gadarla Randheer [1 ]
Miller, Stephen C. [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA
基金
美国国家卫生研究院;
关键词
FIREFLY LUCIFERASE; INHIBITOR; DISCOVERY; ENZYME; FAAH;
D O I
10.1021/jacs.5b04357
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Firefly luciferase is homologous to fatty acyl-CoA synthetases. We hypothesized that the firefly luciferase substrate d-luciferin and its analogs are fatty acid mimics that are ideally suited to probe the chemistry of enzymes that release fatty acid products. Here, we synthesized luciferin amides and found that these molecules are hydrolyzed to substrates for firefly luciferase by the enzyme fatty acid amide hydrolase (FAAH). In the presence of luciferase, these molecules enable highly sensitive and selective bioluminescent detection of FAAH activity in vitro, in live cells, and in vivo. The potency and tissue distribution of FAAH inhibitors can be imaged in live mice, and luciferin amides serve as exemplary reagents for greatly improved bioluminescence imaging in FAAH-expressing tissues such as the brain.
引用
收藏
页码:8684 / 8687
页数:4
相关论文
共 50 条
  • [1] Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo
    Lichtman, AH
    Hawkins, EG
    Griffin, G
    Cravatt, BF
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (01): : 73 - 79
  • [2] Intracellular Self-Assembly of Cyclic D-Luciferin Nanoparticles for Persistent Bioluminescence Imaging of Fatty Acid Amide Hydrolase
    Yuan, Yue
    Wang, Fuqiang
    Tang, Wei
    Ding, Zhanling
    Wang, Lin
    Liang, Lili
    Zheng, Zhen
    Zhang, Huafeng
    Liang, Gaolin
    ACS Nano, 2016, 10 (07) : 7147 - 7153
  • [3] Identification of Endogenous Inhibitors of Fatty Acid Amide Hydrolase in the Liver
    Liu, Jie
    Cinar, Resat
    Xiong, Keming
    Ntambi, James M.
    Kunos, George
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [4] Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseases
    Pillarisetti, Sivaram
    Alexander, Christopher W.
    Khanna, Ish
    DRUG DISCOVERY TODAY, 2009, 14 (23-24) : 1098 - 1111
  • [5] Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide
    Day, TA
    Rakhshan, F
    Deutsch, DG
    Barker, EL
    MOLECULAR PHARMACOLOGY, 2001, 59 (06) : 1369 - 1375
  • [6] Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain
    Glaser, ST
    Gatley, SJ
    Gifford, AN
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (03): : 1088 - 1097
  • [7] Fatty acid amide hydrolase controls mouse intestinal motility in vivo
    Capasso, R
    Matias, I
    Lutz, B
    Borrelli, F
    Capasso, F
    Marsicano, G
    Mascolo, N
    Petrosino, S
    Monory, K
    Valenti, M
    Di Marzo, V
    Izzo, AA
    GASTROENTEROLOGY, 2005, 129 (03) : 941 - 951
  • [8] Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide
    Calignano, A
    La Rana, G
    Piomelli, D
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 419 (2-3) : 191 - 198
  • [9] The fatty acid amide hydrolase (FAAH)
    Ueda, N
    Puffenbarger, RA
    Yamamoto, S
    Deutsch, DG
    CHEMISTRY AND PHYSICS OF LIPIDS, 2000, 108 (1-2) : 107 - 121
  • [10] The fatty acid amide hydrolase (FAAH)
    Deutsch, DG
    Ueda, N
    Yamamoto, S
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2002, 66 (2-3): : 201 - 210